Financhill
Sell
14

CYTK Quote, Financials, Valuation and Earnings

Last price:
$29.99
Seasonality move :
11.45%
Day range:
$30.46 - $32.95
52-week range:
$30.46 - $61.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
184.58x
P/B ratio:
61.87x
Volume:
3.5M
Avg. volume:
2.6M
1-year change:
-47.12%
Market cap:
$3.7B
Revenue:
$18.5M
EPS (TTM):
-$5.29

Earnings Data

Next earnings date for CYTK
Aug 08
2025
Most recent earnings per share
-$1.36
Beat by $0.00
(May 6/2025)
Consensus Estimate
-$1.36
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CYTK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $2M -- -- -$1.41 --
05/06/2025 Q1 $2.6M $1.6M -$1.36 -$1.36 $0.00
02/27/2025 Q4 $14.3M $16.9M -$1.26 -$1.17 -$0.09
11/06/2024 Q3 $1.2M $463K -$1.36 -$1.24 -$0.12
08/08/2024 Q2 $21M $249K -$1.31 -$0.91 -$0.40
05/08/2024 Q1 $906.6K $835K -$1.33 -$1.17 -$0.16
02/27/2024 Q4 $13.3M $1.7M -$1.38 -$0.95 -$0.43
11/02/2023 Q3 -- -- -$1.35 -$0.76 -$0.59
08/03/2023 Q2 -- -- -$1.34 -$1.24 -$0.10
05/04/2023 Q1 -- -- -$1.38 -$1.18 -$0.20
03/01/2023 Q4 -- -- -$1.45 -$1.19 -$0.26
11/03/2022 Q3 -- -- -$1.52 -$1.17 -$0.35
08/04/2022 Q2 -- -- -$0.23 -$1.01 $0.78
05/04/2022 Q1 -- -- -$1.05 -$0.94 -$0.11
02/24/2022 Q4 -- -- -$0.36 -$0.84 $0.48
11/03/2021 Q3 -- -- -$0.95 -$0.77 -$0.18
08/05/2021 Q2 -- -- -$0.86 -$0.66 -$0.20
05/06/2021 Q1 -- -- -$0.66 -$0.61 -$0.05
02/25/2021 Q4 -- -- -$0.62 -$0.46 -$0.16
11/04/2020 Q3 -- -- -$0.05 -$0.34 $0.29
08/06/2020 Q2 -- -- -$0.68 -$0.57 -$0.11
05/06/2020 Q1 -- -- -$0.66 -$0.51 -$0.15
03/03/2020 Q4 -- -- -$0.51 -$0.44 -$0.07
10/31/2019 Q3 -- -- -$0.50 -$0.49 -$0.01
08/08/2019 Q2 -- -- -- -$0.50 --
05/09/2019 Q1 -- -- -- -$0.47 --
02/21/2019 Q4 -- -- -- -$0.52 --
11/01/2018 Q3 -- -- -- -$0.52 --
07/26/2018 Q2 -- -- -- -$0.51 --
04/26/2018 Q1 -- -- -- -- --
02/15/2018 Q4 -- -- -- -- --
10/26/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
04/27/2017 Q1 -- -- -- -- --
02/16/2017 Q4 -- -- -- -- --
10/27/2016 Q3 -- -- -- -- --
07/28/2016 Q2 -- -- -- -- --
04/28/2016 Q1 -- -- -- -- --
02/16/2016 Q4 -- -- -- -- --
10/29/2015 Q3 -- -- -- -- --
07/29/2015 Q2 -- -- -- -- --

Cytokinetics Earnings Questions

  • How Much did Cytokinetics Generate in Revenue Last Quarter?

    Cytokinetics reported $1.6M worth of top line sales in its most recent quarter.

  • Did Cytokinetics Beat Earnings Last Quarter?

    Cytokinetics announced earnings per share of -$1.36 which represents a beat of analyst forecast a -$1.36 per share.

  • Is Cytokinetics Profitable?

    Cytokinetics reported -$98.3M that represents -$0.83 per share over the last quarter.

  • What is the Analyst Consensus for Cytokinetics EPS Next Year?

    Cytokinetics's earnings are forecast to decrease from -$5.26 per share to -$5.16 per share next year representing a decrease of -9.11%.

  • When is Cytokinetics's Earnings Date?

    Cytokinetics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock